• Ms.Amy Lu
    Tel: 027-84306245

  • Mobile:
  • Tel:027-84306245
  • Fax:
  • URL:http://www.wondapharm.com
  • Province/state:Hubei
  • City:Wuhan
  • Street:Wuhan Private Science and Technology Park , Wuhan, China
  • MaxCard:
Home > Products >  Factory Supply Finasteride With Best Quality

Factory Supply Finasteride With Best Quality CAS NO.98319-26-7

  • Min.Order: 10 Gram
  • Payment Terms: T/T,MoneyGram
  • Product Details

Keywords

  • Finasteride
  • Finasteride powder
  • CAS 98319-26-7

Quick Details

  • ProName: Factory Supply Finasteride With Best Q...
  • CasNo: 98319-26-7
  • Molecular Formula: C23H36N2O2
  • Appearance: white powder
  • Application: for research
  • DeliveryTime: immediately
  • PackAge: discreet packing
  • Port: HK, Shanghai, Shenzhen
  • ProductionCapacity: 500 Kilogram/Month
  • Purity: 99%
  • Storage: cool and dry place
  • Transportation: email:wonda-chem@outlook.com
  • LimitNum: 10 Gram

Superiority

1.high quality:

quality is life. quality is the most important element for all goods. we have a lab doing research in wuhan china. hplc and nmr is available if needed.

2.reasonable price:

we provide high quality products with competitive price in china. all customers are welcomed to send us inquiries and get quotation.

3.low moq:

no worry about the low moq, our moq is 1 gram or even lower.

4.good service.

fast response. we promise to reply within 24 hours including holidays and send quotation sheet and other documents within 48 hours.

5. fast shipping and secure courier.

we promise to send out products and provide tracking number within 3 working days. and we send via different couriers based on different destination countries. we usually use nl post, hk post, germany post, eub, etk, etc.

 

 

Details

Product Name: Finasteride

Specification: 99%

Cas No: 98319-26-7

Appearance: White powder

Molecular formula: C23H36N2O2

Molecular weight: 372.54g/mol

Finasteride is an antiandrogen which acts by inhibiting type II 5-alpha reductase.It is used as a treatment in 

benign prostatic hyperplasia (BPH) in low doses, and prostate cancer in higher doses. It is also indicated for use in combination with doxazosin therapy to reduce the risk for symptomatic progression of BPH. Additionally, it is registered in many countries for androgenetic alopecia (male-pattern baldness).

Finasteride was approved initially in 1992, a treatment for prostate enlargement, but the sponsor had studied 1 mg of finasteride and demonstrated hair growth in male pattern hair loss. On December 22, 1997, the FDA approved finasteride to treat male pattern hair loss.

 

 

 

 

Packing and shipping

 

 

 

 

 

 

Other products of this supplier

lookchemhot product CAS New CAS Cas Database Article Data Chemical Catalog